When the Primary Endpoint Changes Mid-Trial: The Amendment Playbook Sponsors Get Wrong
An intra-arterial alteplase trial changed its primary outcome at month 12 after 283 enrollments. Here's the clinops reality of...
ICH E9(R1)
An intra-arterial alteplase trial changed its primary outcome at month 12 after 283 enrollments. Here's the clinops reality of...